Neurology Archive

A building with a stone facade displays a sign that reads
David Wang, D.O., FAHA, FAAN
A building with a stone facade displays a sign that reads
Suraj Muley, M.D., FAAN, FRCP
A building with a stone facade displays a sign that reads
Donald B. Penzien, Ph.D., FAHS, FSBM
A building with a stone facade displays a sign that reads
Ashutosh P. Jadhav, M.D., Ph.D.
A building with a stone facade displays a sign that reads
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
A building with a stone facade displays a sign that reads
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis
A building with a stone facade displays a sign that reads
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (Stride Dystonia)
A building with a stone facade displays a sign that reads
An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (GBS) (FORWARD Study)
A building with a stone facade displays a sign that reads
Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Outcomes and Exploration of Mechanisms
A building with a stone facade displays a sign that reads
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy